| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| ROG.SW - | BUY | 607 @ CHF 274.637 | CHF 166,705 | The ETF bought 607 new shares of ROG.SW (). The shares were bought for an average price of 274.637 compared to the previous average buy price of 289.065. This is -5.0% lower than average price of previous purchases of ROG.SW. |
| NOVN.SW - | BUY | 1,704 @ CHF 97.38 | CHF 165,936 | The ETF bought 1704 new shares of NOVN.SW (). The shares were bought for an average price of 97.38 compared to the previous average buy price of 97.8035. This is -0.4% lower than average price of previous purchases of NOVN.SW. |
| AZN.L - AstraZeneca PLC | BUY | 1,341 @ GBP 118.035 | GBP 158,285 | The ETF bought 1341 new shares of AZN.L (AstraZeneca PLC). The shares were bought for an average price of 118.035 compared to the previous average buy price of 130.736. This is -9.7% lower than average price of previous purchases of AZN.L. |
| SAN.PA - Sanofi SA | BUY | 983 @ EUR 90.71 | EUR 89,168 | The ETF bought 983 new shares of SAN.PA (Sanofi SA). The shares were bought for an average price of 90.71 compared to the previous average buy price of 97.8777. This is -7.3% lower than average price of previous purchases of SAN.PA. |
| EL.PA - EssilorLuxottica SA | BUY | 257 @ EUR 247.3 | EUR 63,556 | The ETF bought 257 new shares of EL.PA (EssilorLuxottica SA). The shares were bought for an average price of 247.3 compared to the previous average buy price of 249.655. This is -0.9% lower than average price of previous purchases of EL.PA. |
| GSK.L - GlaxoSmithKline PLC | BUY | 3,583 @ GBP 15.5822 | GBP 55,831 | The ETF bought 3583 new shares of GSK.L (GlaxoSmithKline PLC). The shares were bought for an average price of 15.5822 compared to the previous average buy price of 16.7685. This is -7.1% lower than average price of previous purchases of GSK.L. |
| LONN.SW - | BUY | 62 @ CHF 579.359 | CHF 35,920 | The ETF bought 62 new shares of LONN.SW (). The shares were bought for an average price of 579.359 compared to the previous average buy price of 574.681. This is 0.8% higher than average price of previous purchases of LONN.SW. |
| ALC.SW - | BUY | 432 @ CHF 80.9942 | CHF 34,989 | The ETF bought 432 new shares of ALC.SW (). The shares were bought for an average price of 80.9942 compared to the previous average buy price of 82.745. This is -2.1% lower than average price of previous purchases of ALC.SW. |
| HLN.L - Haleon PLC | BUY | 7,827 @ GBP 4.43623 | GBP 34,722 | The ETF bought 7827 new shares of HLN.L (Haleon PLC). The shares were bought for an average price of 4.43623 compared to the previous average buy price of 4.68254. This is -5.3% lower than average price of previous purchases of HLN.L. |
| ARGX.BR - Argenx SE | BUY | 52 @ EUR 524.2 | EUR 27,258 | The ETF bought 52 new shares of ARGX.BR (Argenx SE). The shares were bought for an average price of 524.2 compared to the previous average buy price of 575.954. This is -9.0% lower than average price of previous purchases of ARGX.BR. |
| BAYN.DE - Bayer AG | BUY | 849 @ EUR 21.03 | EUR 17,854 | The ETF bought 849 new shares of BAYN.DE (Bayer AG). The shares were bought for an average price of 21.03 compared to the previous average buy price of 21.037. This is 0.0% lower than average price of previous purchases of BAYN.DE. |
| UCB.BR - UCB SA | BUY | 109 @ EUR 136.3 | EUR 14,857 | The ETF bought 109 new shares of UCB.BR (UCB SA). The shares were bought for an average price of 136.3 compared to the previous average buy price of 179.631. This is -24.1% lower than average price of previous purchases of UCB.BR. |
| PHIA.AS - Koninklijke Philips NV | BUY | 691 @ EUR 20.94 | EUR 14,470 | The ETF bought 691 new shares of PHIA.AS (Koninklijke Philips NV). The shares were bought for an average price of 20.94 compared to the previous average buy price of 24.2436. This is -13.6% lower than average price of previous purchases of PHIA.AS. |
| FRE.DE - Fresenius SE & Co KGaA | BUY | 365 @ EUR 39.01 | EUR 14,239 | The ETF bought 365 new shares of FRE.DE (Fresenius SE & Co KGaA). The shares were bought for an average price of 39.01 compared to the previous average buy price of 35.7153. This is 9.2% higher than average price of previous purchases of FRE.DE. |
| MRK.DE - Merck KGaA | BUY | 112 @ EUR 116.65 | EUR 13,065 | The ETF bought 112 new shares of MRK.DE (Merck KGaA). The shares were bought for an average price of 116.65 compared to the previous average buy price of 136.276. This is -14.4% lower than average price of previous purchases of MRK.DE. |
| SDZ.SW - | BUY | 361 @ CHF 34.9528 | CHF 12,618 | The ETF bought 361 new shares of SDZ.SW (). The shares were bought for an average price of 34.9528 compared to the previous average buy price of 39.7514. This is -12.1% lower than average price of previous purchases of SDZ.SW. |
| SOON.SW - | BUY | 44 @ CHF 254.759 | CHF 11,209 | The ETF bought 44 new shares of SOON.SW (). The shares were bought for an average price of 254.759 compared to the previous average buy price of 301.597. This is -15.5% lower than average price of previous purchases of SOON.SW. |
| SHL.DE - Siemens Healthineers AG | BUY | 243 @ EUR 44.66 | EUR 10,852 | The ETF bought 243 new shares of SHL.DE (Siemens Healthineers AG). The shares were bought for an average price of 44.66 compared to the previous average buy price of 51.351. This is -13.0% lower than average price of previous purchases of SHL.DE. |
| STMN.SW - | BUY | 97 @ CHF 104.138 | CHF 10,101 | The ETF bought 97 new shares of STMN.SW (). The shares were bought for an average price of 104.138 compared to the previous average buy price of 120.847. This is -13.8% lower than average price of previous purchases of STMN.SW. |
| SN.L - Smith & Nephew PLC | BUY | 720 @ GBP 11.4678 | GBP 8,257 | The ETF bought 720 new shares of SN.L (Smith & Nephew PLC). The shares were bought for an average price of 11.4678 compared to the previous average buy price of 12.9824. This is -11.7% lower than average price of previous purchases of SN.L. |
| RO.SW - | BUY | 28 @ CHF 289.894 | CHF 8,117 | The ETF bought 28 new shares of RO.SW (). The shares were bought for an average price of 289.894 compared to the previous average buy price of 305.639. This is -5.2% lower than average price of previous purchases of RO.SW. |
| FME.DE - Fresenius Medical Care AG | BUY | 179 @ EUR 41.58 | EUR 7,443 | The ETF bought 179 new shares of FME.DE (Fresenius Medical Care AG). The shares were bought for an average price of 41.58 compared to the previous average buy price of 44.4066. This is -6.4% lower than average price of previous purchases of FME.DE. |
| GALD.SW - | BUY | 82 @ CHF 84.4003 | CHF 6,921 | The ETF bought 82 new shares of GALD.SW (). The shares were bought for an average price of 84.4003 compared to the previous average buy price of 97.2295. This is -13.2% lower than average price of previous purchases of GALD.SW. |
| QIA.DE - QIAGEN NV | BUY | 187 @ EUR 35.98 | EUR 6,728 | The ETF bought 187 new shares of QIA.DE (QIAGEN NV). The shares were bought for an average price of 35.98 compared to the previous average buy price of 36.5498. This is -1.6% lower than average price of previous purchases of QIA.DE. |
| ERF.PA - Eurofins Scientific SE | BUY | 117 @ EUR 49.57 | EUR 5,800 | The ETF bought 117 new shares of ERF.PA (Eurofins Scientific SE). The shares were bought for an average price of 49.57 compared to the previous average buy price of 48.9498. This is 1.3% higher than average price of previous purchases of ERF.PA. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | BUY | 100 @ EUR 48.36 | EUR 4,836 | The ETF bought 100 new shares of REC.MI (Recordati Industria Chimica e Farmaceutica SpA). The shares were bought for an average price of 48.36 compared to the previous average buy price of 52.7232. This is -8.3% lower than average price of previous purchases of REC.MI. |
| SRT3.DE - Sartorius AG | BUY | 23 @ EUR 209 | EUR 4,807 | The ETF bought 23 new shares of SRT3.DE (Sartorius AG). The shares were bought for an average price of 209 compared to the previous average buy price of 222.106. This is -5.9% lower than average price of previous purchases of SRT3.DE. |
| DIM.PA - Sartorius Stedim Biotech | BUY | 25 @ EUR 187.15 | EUR 4,679 | The ETF bought 25 new shares of DIM.PA (Sartorius Stedim Biotech). The shares were bought for an average price of 187.15 compared to the previous average buy price of 187.348. This is -0.1% lower than average price of previous purchases of DIM.PA. |
| ORNBV.HE - Orion Oyj | BUY | 94 @ EUR 49.08 | EUR 4,614 | The ETF bought 94 new shares of ORNBV.HE (Orion Oyj). The shares were bought for an average price of 49.08 compared to the previous average buy price of 47.9229. This is 2.4% higher than average price of previous purchases of ORNBV.HE. |
| BIM.PA - BioMerieux | BUY | 36 @ EUR 113.7 | EUR 4,093 | The ETF bought 36 new shares of BIM.PA (BioMerieux). The shares were bought for an average price of 113.7 compared to the previous average buy price of 108.326. This is 5.0% higher than average price of previous purchases of BIM.PA. |
| HIK.L - | BUY | 145 @ GBP 21.9771 | GBP 3,187 | The ETF bought 145 new shares of HIK.L (). The shares were bought for an average price of 21.9771 compared to the previous average buy price of 24.5528. This is -10.5% lower than average price of previous purchases of HIK.L. |
| IPN.PA - Ipsen SA | BUY | 33 @ EUR 90.7 | EUR 2,993 | The ETF bought 33 new shares of IPN.PA (Ipsen SA). The shares were bought for an average price of 90.7 compared to the previous average buy price of 109.524. This is -17.2% lower than average price of previous purchases of IPN.PA. |
| AMP.MI - Amplifon SpA | BUY | 109 @ EUR 16.21 | EUR 1,767 | The ETF bought 109 new shares of AMP.MI (Amplifon SpA). The shares were bought for an average price of 16.21 compared to the previous average buy price of 23.5373. This is -31.1% lower than average price of previous purchases of AMP.MI. |
| SOBI.ST - | HOLD | 0 @ SEK 24.0259 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 24.0259. The average price that SOBI.ST shares were previous bought at was SEK 26.9845. The current market price is -11.0% lower than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 41,740 (USD $4,280) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 29.9449 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 29.9449. The average price that DEMANT.CO shares were previous bought at was DKK 34.6261. The current market price is -13.5% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 134 (USD $20) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 8.068 | EUR 0 | |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 56.4146 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 56.4146. The average price that NOVO-B.CO shares were previous bought at was DKK 72.6601. The current market price is -22.4% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 9,047 (USD $1,381) compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 94.0667 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 94.0667. The average price that COLO-B.CO shares were previous bought at was DKK 99.4698. The current market price is -5.4% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 591 (USD $90) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 56.8498 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 56.8498. The average price that ZEAL.CO shares were previous bought at was DKK 83.2446. The current market price is -31.7% lower than average price they were purchased at. The value of the holding in ZEAL.CO has increased by DKK 183 (USD $28) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 172.96 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 172.96. The average price that GMAB.CO shares were previous bought at was DKK 195.655. The current market price is -11.6% lower than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 543 (USD $83) compared to the previous valuation of however if the holding was sold on 2025-04-17 this would crystalise an overall loss. |
| DIA.MI - DiaSorin SpA | SELL | -820 @ EUR 97.92 | EUR -80,294 | The ETF sold 820 shares of DIA.MI on 2025-04-17. The shares were previously bought for an average price of EUR 99.7953. The DiaSorin SpA shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 1,538 (USD $1,753) The average price that the ETF previously sold DIA.MI share for is EUR 99.1649 which is higher than the selling price of EUR 97.92 on 2025-04-17. |